Cowingene HPV 28 Genotyping Detection Kit - Taizhou Cowingene Biotech Co., Ltd.

Human Papillomavirus (HPV) remains one of the most significant public health challenges globally, with over 200 identified subtypes. Among these, HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 81, 82, 83 are classified as high-risk, linked to cervical cancer and other malignancies. The Cowingene HPV 28 Genotyping Detection Kit (Liquid) offers a cutting-edge solution for accurate, high-throughput detection of these critical HPV subtypes. Developed by Taizhou Cowingene Biotech Co., Ltd., this kit combines advanced molecular biology techniques with user-friendly design to meet the demands of modern diagnostic laboratories.

Key Features and Advantages

• High Sensitivity and Specificity: Utilizes PCR (Polymerase Chain Reaction) technology for precise amplification and detection of HPV DNA.
• Comprehensive Coverage: Detects 28 high-risk HPV subtypes, including HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 81, 82, 83.
• Flexible Sample Types: Accepts Cervical swab, Urine, and Self-collected vaginal specimens, enhancing patient compliance and convenience.
• Efficient Workflow: Designed for rapid processing, reducing time-to-result without compromising accuracy.
• Scalable for High-Throughput Testing: Ideal for large-scale screening programs and clinical laboratories.

Technical Specifications

Parameter	Details
Product Name	Cowingene HPV 28 Genotyping Detection Kit (Liquid)
Company	Taizhou Cowingene Biotech Co., Ltd.
Validated Specimens	Cervical swab, Urine, Self-collected vaginal
Detected HPV Subtypes	28 high-risk types: 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83
Technology	PCR-based genotyping
Sample Type	Fluid-based specimens (e.g., cervical swabs, urine)
Kit Components	8 tubes for multiplex detection

Applications and Use Cases

The Cowingene HPV 28 Genotyping Detection Kit is designed for a wide range of applications, including:

• Cervical Cancer Screening: Identifies high-risk HPV subtypes associated with cervical intraepithelial neoplasia (CIN) and invasive cancer.
• Public Health Surveillance: Supports large-scale epidemiological studies to monitor HPV prevalence and vaccine efficacy.
• Research and Development: Provides reliable data for studies on HPV pathogenesis, drug development, and diagnostic innovation.
• Point-of-Care Testing: Suitable for decentralized testing in clinics and mobile health units.

Company Background: Taizhou Cowingene Biotech Co., Ltd.

Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and infectious disease testing. With a focus on innovation, quality, and accessibility, the company develops cutting-edge solutions for global healthcare challenges. Their products are designed to meet international standards, ensuring accuracy, reliability, and compliance with regulatory requirements.

References and Authority

The information provided in this article is validated by scientific literature and industry standards. For further details on HPV detection methodologies, refer to the National Institute of Standards and Technology (NIST) guidelines on molecular diagnostic testing.

Product Images

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit represents a significant advancement in HPV diagnostics, offering a robust, scalable, and user-friendly solution for laboratories worldwide. By combining PCR technology with comprehensive subtype coverage, this kit empowers healthcare providers to deliver accurate, timely results that improve patient outcomes and public health strategies.

For more information, visit the product page or contact Taizhou Cowingene Biotech Co., Ltd. directly.